One of the most common cancers in the world, it is the leading cause of cancer related deaths in the world. It accounts for the highest mortality rates among men and women. However, this has become a rising issue among women. A 2014 study published in the Seminars in Thoracic and Cardiovascular Surgery journal explained that historically lung cancer was mainly studied in men because it was very rare in women. However, as social habits changed and more women started smoking, the number of lung cancer cases in women increased. They mentioned that lung cancer often behaves differently in women than it does in men, especially in non-smokers. This review looks at these differences, including risk factors, how the disease develops, and treatment options. Lung Cancer in Women In the United States, lung cancer is the second most common cancer in women and the top cause of cancer-related death. Here are some important statistics from 2012: There were an estimated 109,690 new diagnoses in women.Lung cancer caused an estimated 72,590 deaths in women, which was more than the number of deaths from breast and colon cancer combined.The 5-year survival rate for women is about 18%, which is slightly better than the 14% rate for men, but it is still very low.Globally, lung cancer cases and deaths in women are still on the rise, especially in countries where more women are starting to smoke.What Are Some Risk Factors Other Than Smoking? Smoking is still the biggest cause of lung cancer in women, responsible for 80-90% of cases. However, a significant number of women who get lung cancer have never smoked. Women married to men who smoke have a 25-29% higher risk of getting lung cancer.Burning cooking oil or other fuels indoors in areas with poor airflow, especially in developing countries, is a major risk factor.A family history of lung cancer increases a woman's risk more than a man's.Hormones like estrogen may play a role in the development of lung cancer. Studies in some women, particularly in East Asia, have linked the human papillomavirus (HPV) to lung cancer.What Are Some Challenges Women Face With Lung Cancer Diagnosis? According to Lungevity, women often face delays and hurdles in getting a lung cancer diagnosis, which can worsen their chances of survival. Diagnosis Delays Women are less likely to seek help for early symptoms and can experience longer waiting times between initial doctor visits and a final diagnosis. This can allow the disease to progress before treatment even begins. Lack of Screening Many women are not offered lung cancer screening. A study found that women of color who are eligible for screening are six times less likely to be offered it than their male counterparts. Outdated Rules Even with recent updates to screening guidelines in the Center of Disease Control and Prevention, which now include people aged 50 and older and with a smoking history of at least 20 pack-years, many women still don't qualify. This is a major issue because a large number of women with lung cancer have a limited smoking history, which means they are often overlooked. What Other Ways Does Lung Cancer Affect Women The impact of lung cancer on a woman's well-being is often ignored, yet research shows it's a significant burden. Psychological Distress Women with lung cancer have higher rates of depression and anxiety than men. This stress is often made worse by the stigma of the disease, with many women reporting judgmental comments about smoking, regardless of whether they have a smoking history. Sexual Health Sexual health is often an overlooked part of cancer care for women. A study of 249 women with lung cancer found that 77% experienced moderate to severe sexual dysfunction. The women reported issues like fatigue and shortness of breath during intimacy, as well as vaginal dryness and pain. Lack of Women in Clinical Trials A long-standing problem in healthcare is the low number of women in clinical trials. This makes it difficult to know how effective a treatment is for women specifically. Low Participation Women make up only 40% of participants in clinical trials for diseases that affect them, like cancer. For non-small cell lung cancer, this number has not changed much over the past two decades. Unique Barriers Women face extra challenges in participating in trials, such as being primary caregivers, which limits their time. There are also gender biases from doctors who may assume women are less interested in research. Safety Concerns The lack of female representation is a safety issue. One study found that women were 25% more likely to have severe side effects from cancer treatments, but another study found that they were less likely to report these issues.